Abstract

Novel coronavirus disease is a very infectious respiratory infection transmitted from person-to-person and manifest commonly with fever, dry cough, difficulty breathing, fatigue, myalgia and dyspnea. The World Health Organization (WHO) used the term 2019 novel coronavirus to refer to a coronavirus that affected the lower respiratory tract of patients with pneumonia in Wuhan, China on 29 December 2019. Persons with comorbidities and the aged are most vulnerable to severe disease and accounted for over 40% of deaths globally.

Highlights

  • Novel coronavirus disease is a very infectious respiratory infection transmitted from person-to-person and manifest commonly with fever, dry cough, difficulty breathing, fatigue, myalgia and dyspnea

  • There is high level of awareness about COVID-19 in the public mostly through the media but most of the people do not adhere to the preventive measures to prevent themselves from infection

  • Intensified education and enforcement of the preventive measures will be required to interrupt the chain of transmission since the level of awareness seems not to translate to actual practice of preventing infection

Read more

Summary

Introduction

Novel coronavirus disease is a very infectious respiratory infection transmitted from person-to-person and manifest commonly with fever, dry cough, difficulty breathing, fatigue, myalgia and dyspnea. They often results in a very infectious respiratory disease which is transmitted from person-to-person and manifest most often with fever, dry cough, difficulty in breathing, fatigue, myalgia and dyspnea [1]. There are several coronaviruses known to be circulating in different animal populations that have not yet infected humans. Novel coronavirus disease 19 is the most recent to make the jump to human infection. The coronavirus disease 19 infection is spread from one person to others via droplets produced from the respiratory system of infected people, often during coughing or sneezing

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call